Inhibition of in vitro sickling by liposome-mediated transport of amino acids into intact human red blood cells.
D000596:Amino Acids / Q000097:blood / Q000627:therapeutic use*; D000755:Anemia, Sickle Cell / Q000188:drug therapy*; D000986:Antisickling Agents; D004912:Erythrocytes / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D008081:Liposomes / Q000008:administration & dosage*; D014677:Pharmaceutical Vehicles; D010649:Phenylalanine / Q000627:therapeutic use; D014364:Tryptophan / Q000627:therapeutic use
D000596:Amino Acids; D000986:Antisickling Agents; D008081:Liposomes; D014677:Pharmaceutical Vehicles; D010649:Phenylalanine; D014364:Tryptophan